geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Targeted Treatments In Autism And Fragile X Syndrome


, : Targeted Treatments In Autism And Fragile X Syndrome. Research in Autism Spectrum Disorders 6(4): 1311-1320

Autism is a neurodevelopmental disorder consisting of a constellation of symptoms that sometimes occur as part of a complex disorder characterized by impairments in social interaction, communication and behavioral domains. It is a highly disabling disorder and there is a need for treatment targeting the core symptoms. Although autism is accepted as highly heritable, there is no genetic cure at this time. Autism is shown to be linked to several genes and is a feature of some complex genetic disorders, including fragile X syndrome (FXS), fragile X premutation involvement, tuberous sclerosis and Rett syndrome. The term autism spectrum disorders (ASDs) covers autism, Asperger syndrome and pervasive developmental disorders (PDD-NOS) and the etiologies are heterogeneous. In recent years, targeted treatments have been developed for several disorders that have a known specific genetic cause leading to autism. Since there are significant molecular and neurobiological overlaps among disorders, targeted treatments developed for a specific disorder may be helpful in ASD of unknown etiology. Examples of this are two drug classes developed to treat FXS, Arbaclofen, a GABAB agonist, and mGluR5 antagonists, and both may be helpful in autism without FXS. The mGluR5 antagonists are also likely to have a benefit in the aging problems of fragile X premutation carriers, the fragile X-associated tremor ataxia syndrome (FXTAS) and the Parkinsonism that can occur in aging patients with fragile X syndrome. Targeted treatments in FXS which has a well known genetic etiology may lead to new targeted treatments in autism. There is a need for efficient treatments in ASDs which has a heterogeneous etiology. Autism is caused by single-gene disorders in some cases including fragile X syndrome. Targeted treatments in FXS may be a good starting point for targeted treatments in ASDs.

US$19.90

PMID: 23162607

DOI: 10.1016/j.rasd.2012.05.007


Other references

Merkulov, V.M.; Merkulova, T.I., 2009: Structural variants of glucocorticoid receptor binding sites and different versions of positive glucocorticoid responsive elements: Analysis of GR-TRRD database. The GR-TRRD section of the TRRD database contains the presently largest sample of published nucleotide sequences with experimentally confirmed binding to the glucocorticoid hormone receptor (GR). This sample comprises 160 glucocorticoid receptor b...

Shah, M.; Haylett, D.G., 1999: The effects of clotrimazole on the sAHP and Ca++ currents in hippocampal pyramidal neurons. Society for Neuroscience Abstracts 25(1-2): 1987

Krull, C.; Böhme, B.; Clausen, P-Henning.; Nijhof, A.M., 2017: Optimization of an artificial tick feeding assay for Dermacentor reticulatus. The development of standardized in vitro feeding methods for ixodid ticks has been hampered by their complex feeding behaviour and the long duration of their blood meal. In this study, we aimed to optimize several parameters for the in vitro feedi...

Martos-Moreno, G.Ángel.; Barrios, V.; Chowen, J.A.; Argente, Jús., 2013: Adipokines in childhood obesity. The worldwide increase in the prevalence of obesity in children and adolescents during the past decades, in addition to mounting evidence indicating that obesity is associated with an increased incidence of comorbidities and the risk of premature...

Armstrong, D.G.; Lavery, L.A.; Wu, S.; Boulton, A.J.M., 2005: Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. OBJECTIVE:--The purpose of this study was to evaluate the effectiveness of a removable cast walker (RCW) and an "instant" total contact cast (iTCC) in healing neuropathic diabetic foot ulcerations. RESEARCH DESIGN AND METHODS--We randoml...

Salaspuro, M., 1982: Treatment and prognosis of alcoholic liver disease. Duodecim; Laaketieteellinen Aikakauskirja 98(20): 1463-1469

Gunzburg, M., 1995: The use of combined individual, group, and marital therapy to resolve the narcissistic transference. This case study illustrates how combined therapy (individual, group, and marital) by the same therapist was used to resolve a woman's narcissistic transference. The author's position is that combined therapy creates a psychologically sti...

Lareau-Trudel, E.; L.T.oter, A.; Ghattas, B.; Pouget, J.; Attarian, S.; Bendahan, D.; Salort-Campana, E., 2016: Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1. Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is the third most common inherited muscular dystrophy. Considering the highly variable clinical expression and the slow disease progression, sensitive outcome measures would be of interest. Usi...

Rizzo, G.; Capponi, A.; Rinaldo, D.; Arduini, D.; Romanini, C., 1995: Fetal fibronectin in cervical secretions after mid-trimester amniocentesis. Prenatal Diagnosis 15(11): 1087-1088

Petty, T.L., 1987: New initiatives in pulmonary subspecialty training: quantity or quality?. American Review of Respiratory Disease 135(4): 780-782